|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 10701670.1 (espacenet) (Federated) (European Patent Register), 20100127 | Patent/reg. no. and date | DK/EP 2391893, 20140903 | Publication date | 20111207 | Priority no. and date | EP 09151865, 20090202 | EP pub. no. and date |
EP 2391893 20111207 | Effective date | | Applicant/owner | Boehringer Ingelheim International GmbH, Binger Straße 173
55216 Ingelheim am Rhein, DE | Applicant ref. no. | 158543 | Inventor | STANGIER, Joachim, Boehringer Ingelheim GmbH Patents Binger Str. 173
55216 Ingelheim Am Rhein, DE | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 9/19 (2006.01) , G01N 33/94 (2006.01) , G01N 33/96 (2006.01) | Title | Lyofiliseret dabigatran | Int. application no. | EP2010050925 | Int. publication no. | WO2010086329 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |